Adient Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | $0.370 |
| EPS actual | $0.520 |
| EPS Surprise | 40.54% |
| Revenue estimate | 3.616B |
| Revenue actual | 3.865B |
| Revenue Surprise | 6.90% |
| Release date | Feb 04, 2026 |
| EPS estimate | $0.184 |
| EPS actual | $0.350 |
| EPS Surprise | 90.22% |
| Revenue estimate | 3.462B |
| Revenue actual | 3.644B |
| Revenue Surprise | 5.25% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.550 |
| EPS actual | $0.520 |
| EPS Surprise | -5.45% |
| Revenue estimate | 3.525B |
| Revenue actual | 3.688B |
| Revenue Surprise | 4.62% |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.470 |
| EPS actual | $0.450 |
| EPS Surprise | -4.26% |
| Revenue estimate | 3.52B |
| Revenue actual | 3.741B |
| Revenue Surprise | 6.28% |
Last 4 Quarters for Adient
Below you can see how ADNT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $22.88 |
| EPS estimate | $0.470 |
| EPS actual | $0.450 |
| EPS surprise | -4.26% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $21.44 |
| Aug 01, 2025 | $21.40 |
| Aug 04, 2025 | $21.71 |
| Aug 05, 2025 | $22.11 |
| Aug 06, 2025 | $22.88 |
| Aug 07, 2025 | $22.74 |
| Aug 08, 2025 | $21.99 |
| Aug 11, 2025 | $21.87 |
| Aug 12, 2025 | $22.93 |
| 4 days before | 6.72% |
| 4 days after | 0.219% |
| On release day | -0.612% |
| Change in period | 6.95% |
| Release date | Nov 05, 2025 |
| Price on release | $19.98 |
| EPS estimate | $0.550 |
| EPS actual | $0.520 |
| EPS surprise | -5.45% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $23.16 |
| Oct 31, 2025 | $23.19 |
| Nov 03, 2025 | $24.20 |
| Nov 04, 2025 | $23.99 |
| Nov 05, 2025 | $19.98 |
| Nov 06, 2025 | $18.98 |
| Nov 07, 2025 | $19.62 |
| Nov 10, 2025 | $19.72 |
| Nov 11, 2025 | $20.55 |
| 4 days before | -13.73% |
| 4 days after | 2.85% |
| On release day | -5.01% |
| Change in period | -11.27% |
| Release date | Feb 04, 2026 |
| Price on release | $24.26 |
| EPS estimate | $0.184 |
| EPS actual | $0.350 |
| EPS surprise | 90.22% |
| Date | Price |
|---|---|
| Jan 29, 2026 | $21.04 |
| Jan 30, 2026 | $20.80 |
| Feb 02, 2026 | $20.95 |
| Feb 03, 2026 | $21.06 |
| Feb 04, 2026 | $24.26 |
| Feb 05, 2026 | $25.21 |
| Feb 06, 2026 | $26.46 |
| Feb 09, 2026 | $26.03 |
| Feb 10, 2026 | $25.93 |
| 4 days before | 15.30% |
| 4 days after | 6.88% |
| On release day | 3.92% |
| Change in period | 23.24% |
| Release date | May 06, 2026 |
| Price on release | $22.32 |
| EPS estimate | $0.370 |
| EPS actual | $0.520 |
| EPS surprise | 40.54% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $21.05 |
| May 01, 2026 | $21.32 |
| May 04, 2026 | $20.38 |
| May 05, 2026 | $20.67 |
| May 06, 2026 | $22.32 |
| May 07, 2026 | $21.88 |
| May 08, 2026 | $22.78 |
| May 11, 2026 | $22.12 |
| May 12, 2026 | $22.03 |
| 4 days before | 6.03% |
| 4 days after | -1.30% |
| On release day | -1.97% |
| Change in period | 4.66% |
Adient Earnings Call Transcript Summary of Q1 2026
Adient reported a solid start to fiscal 2026 with Q1 revenue of ~$3.6B (up 4% YoY, FX-aided) and adjusted EBITDA of $207M. Management navigated temporary production disruptions (Novella fire, Nexperia shortage, JLR production issues) and expects most volume impacts to recover within the fiscal year. The company raised full-year guidance: sales to ~$14.6B, adjusted EBITDA to ~$880M, and free cash flow to ~$125M, noting production normalization (North America volumes revised higher) and second-half weighted earnings. Adient highlighted growth opportunities from onshoring and conquest wins—now targeting ~$500M incremental revenue (with ~$300M impacting FY2027 and the balance in FY2028)—and is in late-stage quoting on a significant domestic OEM onshoring opportunity. Strategic initiatives include continued automation investments, the ModuTech modular seat solution (cited as delivering meaningful labor/freight savings and floor-space reductions), and stronger exposure to China domestic OEMs (aiming for ~60% of China revenue from domestic OEMs by year-end). Cash/liquidity remains healthy: $855M cash on hand, $1.7B total liquidity, net leverage ~1.7x; returned $25M in buybacks this quarter and reduced borrowing costs with a subsequent TLB refinance. Europe remains challenged by import pressure and lower volumes, but management expects accretive program wins to offset planned strategic actions. Sustainability progress and operational execution were emphasized as competitive advantages driving long-term shareholder value.
Sign In
Buy ADNT